These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1883984)

  • 21. Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
    Piscaglia F; Gaiani S; Siringo S; Gramantieri L; Serra C; Bolondi L
    Aliment Pharmacol Ther; 1998 May; 12(5):475-81. PubMed ID: 9663729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P; Hallemans R; Melot C; Lejeune P; Naeije R
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Itoh Y; Mori T; Takami S; Kashima K
    J Gastroenterol; 1994 Aug; 29(4):460-8. PubMed ID: 7951857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effectiveness of different methods of diagnosis and correction of impaired portal circulation].
    Tadzhiev IIa; Sergienko VB; Tsodikov GV; Tadzhieva NI; Topchiashvili ZA; Sapozhkova LP; Geĭnits AV
    Klin Med (Mosk); 2004; 82(7):43-5. PubMed ID: 15449774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
    Silva G; Fluxá F; Ruiz M; Bresky G; Barrientos C; Backhouse C; Palma M; Iturriaga H
    Rev Med Chil; 1993 Aug; 121(8):889-96. PubMed ID: 8296096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT; Lee FY; Lin HC; Chang TT; Lay CS; Wang SS; Kong CW; Lee SD; Lo KJ
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organic nitrates in portal hypertension.
    Jones AL; Hayes PC
    Am J Gastroenterol; 1994 Jan; 89(1):7-14. PubMed ID: 8273802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sublingual isosorbide dinitrate in portal hypertension.
    Bhatia SJ; Deshmukh H; Abraham P; Shah AV; Vontivillu JA; Jagasia DH; Kothari RH
    Indian J Gastroenterol; 1990 Apr; 9(2):113-5. PubMed ID: 2323797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
    Sánchez del Monte J; Ramos Gómez MV; Velazquez Ochoa E
    Rev Gastroenterol Mex; 2005; 70(3):261-8. PubMed ID: 17063781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation.
    Forrest EH; Jalan R; Redhead DN; Hayes PC
    Aliment Pharmacol Ther; 1996 Oct; 10(5):795-800. PubMed ID: 8899089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of peroral administration of isosorbide dinitrate on portal pressure and flow in patients with liver cirrhosis].
    Cervinka J; Kaláb M; Munclinger M; Kordac V; Tesar V; Marecek Z; Petrtýl J; Perlík F; Brodanová M; Ort J
    Cas Lek Cesk; 1988 Jan; 127(5):140-3. PubMed ID: 3356031
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
    Merkel C; Sacerdoti D; Bolognesi M; Buonamico P; Sticca A; Amodio P; Angeli P; Micotti L; Gatta A
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1221-5. PubMed ID: 10563530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of isosorbide-5-mononitrate on esophageal manometry of cirrhotic patients with esophageal varices].
    Lin XF; Wu JM; Lin XY; Chen MX; Zhu QH; Wu XL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):611-2. PubMed ID: 16092992
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical therapy of portal hypertension due to liver cirrhosis].
    Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
    Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of isosorbide dinitrate (Isoket Pharma-Schwartz) in patients with liver cirrhosis].
    Cervinka J; Kaláb M; Perlík F; Kordac V; Marecek Z; Chmel J; Kodadová J; Horejsí A
    Cas Lek Cesk; 1986 Jul; 125(30):940-3. PubMed ID: 3731233
    [No Abstract]   [Full Text] [Related]  

  • 38. Isosorbide dinitrate in portal hypertensive patients.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R
    J Hepatol; 1992 Nov; 16(3):387. PubMed ID: 1487620
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of propranolol and nitroglycerin on portal pressure and the mechanism of their reducing portal pressure.
    Terada M; Notsumata K; Unoura M; Kobayashi K; Hattori N
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():254-8. PubMed ID: 2519070
    [No Abstract]   [Full Text] [Related]  

  • 40. Angioscintigraphic assessment of hemodynamic effects of penbutolol in cirrhotics with portal hypertension. A double-blind, randomized, controlled study.
    Santambrogio R; Bruno S; Opocher E; Galeotti F; Zatta G; Grugni M; Macri M; Pisani A; Tarolo G; Spina G
    Hepatogastroenterology; 1990 Aug; 37(4):398-402. PubMed ID: 2210607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.